Position in OGN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$338
+$189 QoQ
Shares Held
25
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#544
of 626 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Generali Asset Management SPA SGR holds $334,857,153 across 9 Drug Manufacturers - General names. OGN ranks #9 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
804,933 | $152,631,395 | |
| 2 | LLY |
ELI LILLY & Co
|
63,771 | $76,488,856 | |
| 3 | MRK |
Merck & Co., Inc.
|
303,564 | $39,007,974 | |
| 4 | ABBV |
AbbVie Inc.
|
81,938 | $20,618,878 | |
| 5 | AMGN |
Amgen Inc
|
48,754 | $17,654,798 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
254,617 | $14,671,031 | |
| 7 | BIIB |
Biogen Inc.
|
35,374 | $7,642,906 | |
| 8 | PFE |
Pfizer Inc
|
255,024 | $6,140,977 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $338 | 25 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $149 | 25 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $179 | 25 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $267 | 25 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $242 | 25 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $372 | 25 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $373 | 25 | Shares | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||